Sugi Predict

Sugi Predict / Compounds / SCHEMBL259196

SCHEMBL259196

SCHEMBL259196

NC(=O)c1[nH]c2ncccc2c1NC(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.47
▸ NAMPT P43490 2/20 0.43
▸ KDR P35968 1/20 0.43
▸ AURKA O14965 1/20 0.43
▸ MAPK13 O15264 1/20 0.43
▸ CHEK2 O96017 1/20 0.43
▸ NTRK1 P04629 1/20 0.43
▸ RET P07949 1/20 0.43
▸ HCK P08631 1/20 0.43
▸ FGFR1 P11362 1/20 0.43
▸ FLT4 P35916 1/20 0.43
▸ LIMK1 P53667 1/20 0.43
▸ SIK1 P57059 1/20 0.43
▸ TNK2 Q07912 1/20 0.43
▸ AURKB Q96GD4 1/20 0.43
▸ WNK3 Q9BYP7 1/20 0.43
▸ ADORA3 P0DMS8 2/20 0.42
▸ F2 P00734 2/20 0.42
▸ F12 P00748 1/20 0.42
▸ PLAU P00749 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259336 0.89 MAPT (0.49) NAMPTKDRAURKAMAPK13CHEK2
SCHEMBL259199 0.86 F2 (0.51) ALDH1A1ADORA3F2NPC1RAB9A
SCHEMBL259347 0.82 RAB9A (0.53) ALDH1A1KDRNPC1RAB9ACYP1A2
SCHEMBL259185 0.81 MAPT (0.60) ALDH1A1CYP1A2HPGDKMT2ASMN1; SMN2
SCHEMBL9133248 0.81 MAPT (0.57) ALDH1A1RAB9AMAP2HPGDKMT2A
SCHEMBL12667942 0.77 GAA (0.46) NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL12700457 0.77 LMNA (0.43) NPC1RAB9ASMN1; SMN2
SCHEMBL259348 0.73 ALDH1A1 (0.66) ALDH1A1KDRADORA3NPC1RAB9A
SCHEMBL259346 0.73 LIMK1 (0.57) ALDH1A1KDRLIMK1ADORA3NPC1
SCHEMBL679347 0.70 BRD4 (0.67) ALDH1A1NAMPTAURKAMAPK13CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067586-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2011-11-29 — — US disclosed
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 — — US disclosed
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 — — US disclosed
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 — — US disclosed
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 — — US disclosed
US-20070037805-A1 Fused heteroaryl derivatives HAYAKAWA MASAHIKO 2007-02-15 — — US disclosed
US-20070037805-A1 Fused heteroaryl derivatives HAYAKAWA MASAHIKO 2007-02-15 — — US disclosed
US-7173029-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2007-02-06 — — US disclosed
US-7173029-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2007-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES PIK3CD, PIK3R3, PIK3C2A ALDH1A1 4428/4885NAMPT 2274/4885KDR 628/4885
US-20070037805-A1 Fused heteroaryl derivatives PIK3CD, PIK3R3, PIK3C2A ALDH1A1 4428/4885NAMPT 2274/4885KDR 628/4885
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES PIK3CD, PIK3R3, PIK3C2A ALDH1A1 4428/4885NAMPT 2274/4885KDR 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.